E-drug: EMEA and funding from manufacturers (cont)
---------------------------------------------
I can certainly comment for New Zealand and Australia. Approx 50% of
the costs of Medsafe, the NZ regulator, are funded through fees from
industry,
in Australia a full cost recovery system is in place and 100% of the
costs are recouped from industry fees.
Stewart Jessamine
Senior Advisor (Medical)
Medsafe
Public Health Directorate
Ministry of Health
DDI: 496 2274
mailto:stewart_jessamine@moh.govt.nz
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.